 Home > Active Ingredient News > Drugs Articles > Regeneron acquires Checkmate for $250M, collaborates with SpringWorks on multiple myeloma therapy

Regeneron acquires Checkmate for $250M, collaborates with SpringWorks on multiple myeloma therapy

 Last Update: 2022-06-07
 Source: Internet
 Author: User

Tags

gamma cells

drug therapy definition

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

A few days ago, Regeneron announced the acquisition of Checkmate Pharmaceuticals, and also said that it will cooperate with SpringWorks Therapeutics on a clinical trial to jointly evaluate the efficacy of Regeneron REGN5458 in combination with SpringWorks drug nirogacestat in patients with multiple myeloma

In terms of acquisitions, Regeneron is expected to acquire Checkmate Pharmaceuticals and its subsidiary Vidutolimod, an investigational immune activator, for about $250 million

It is reported that Vidutolimod is a CpG-A oligodeoxynucleotide Toll-like receptor 9 agonist, and the drug is delivered to the patient's body in the form of virus-like particles

In terms of clinical trial cooperation, Regeneron also said it is collaborating with SpringWorks Therapeutics to conduct a clinical trial to evaluate the therapeutic effect of REGEN5458 in combination with nirogacestat

It is understood that nirogacestat is an investigational, oral, selective small molecule gamma-secretase inhibitor in Phase III clinical development trials for noncancerous growths in desmoid tumors that occur in connective tissue

In Phase I clinical trial results, REGN5458 showed a 75% response rate at the highest dose level, with 83% of patients showing a good partial response

Original English text: https:// href="https://" target="_blank">https://

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Best price Pure Tirzepatide powder 10mg vial Tirzepatide CAS 2023788-19-2 ouda

CAS No.: 2023788-19-2

Pharmacy Grade

$40.00/G FOB

Safe Delivery Freeze Dried Peptides Raw Powder Weight Loss Tirze Peptide Sema 5mg 10mg

CAS No.: 2023788-19-2

Pharmacy Grade

$120.00/UNIT FOB

RU 58841 CAS 154992-24-2 RU58841 Powder Bulk RU-58841 For Hair Growth and Anti Hair Loss

CAS No.: 154992-24-2

Pharmacy Grade

$1-1.2/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.